Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Plus Therapeutics Inc
(NQ:
PSTV
)
1.850
+0.310 (+20.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Plus Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
EXCLUSIVE: Plus Therapeutics Lead Candidate Shows Preliminary Safety, Efficacy In Type Of Brain Cancer
August 11, 2023
Plus Therapeutics Inc (NASDAQ: PSTV) reported data from the ReSPECT-LM study evaluating the company’s lead radiotherapeutic, rhenium (186Re) obisbemeda, for
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 05, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Plus Therapeutics: Here's What You Need To Know
June 30, 2023
Via
Benzinga
Plus Therapeutics Earnings Perspective: Return On Capital Employed
April 21, 2023
Via
Benzinga
Plus Therapeutics Releases Early-Cut Data From Cancer Studies For Brain Cancer Settings
June 29, 2023
Plus Therapeutics Inc (NASDAQ: PSTV) reported interim updates from the ReSPECT-GBM and ReSPECT-LM studies of rhenium (186Re) obisbemeda, for recurrent glioblastoma (rGBM)
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Plus Therapeutics – Precision Radiology Is Proving Highly Effective At Fighting Cancer
June 26, 2023
Marc Hedrick, M.D., President and CEO of Plus Therapeutics (NASDAQ: PSTV) was recently a guest on Benzinga’s All-Access.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 16, 2023
Friday's session saw 32 companies set new 52-week lows.
Via
Benzinga
Plus Therapeutics: Q1 Earnings Insights
April 20, 2023
Via
Benzinga
Recap: Plus Therapeutics Q1 Earnings
April 20, 2023
Via
Benzinga
Earnings Preview For Plus Therapeutics
April 19, 2023
Via
Benzinga
Plus Therapeutics Earnings Perspective: Return On Capital Employed
March 01, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 13, 2023
On Tuesday, 32 companies reached new 52-week lows.
Via
Benzinga
This Company Is Developing Novel Treatments For Difficult To Treat CNS Cancers
May 18, 2023
Norman LaFrance, MD, CMO & Senior VP, and Melissa Moore, PhD, VP of Clinical Research for Plus Therapeutics Inc. (NASDAQ: PSTV) were recently interviewed by Benzinga.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 02, 2023
Via
Benzinga
Plus Therapeutics Highlights Updates On Lead Program In Brain Cancer Indications
November 21, 2022
Via
Benzinga
Killing Cancer: Meet This Innovative Biotech Player
October 19, 2022
Sign up for this week’s All Access giveaway here!
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 25, 2023
Tuesday's session saw 286 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
On Tuesday, 74 companies achieved new lows for the year.
Via
Benzinga
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
January 05, 2023
Gainers Vyant Bio, Inc. (NASDAQ: VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.
Via
Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 29, 2022
On Thursday, 116 companies set new 52-week lows.
Via
Benzinga
Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket
November 21, 2022
Gainers EUDA Health Holdings Limited (NASDAQ: EUDA) shares rose 88.1% to $8.40 in pre-market trading after merger completed with 8i Acquisition SPAC last week.
Via
Benzinga
This Company Marks A Milestone In The March Against Cancer
October 27, 2022
Rare Cancer Day on Sept. 30 was an opportunity for many to reflect: What would they give for one more moment with their loved ones? Most people pass the day without considering the precious gift of...
Via
Benzinga
Earnings Scheduled For October 20, 2022
October 20, 2022
Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion.
Via
Benzinga
Earnings Outlook For Plus Therapeutics
October 19, 2022
Plus Therapeutics (NASDAQ:PSTV) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Plus...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.